Targeting GSTM3 for therapeutic potential in advanced prostate cancer. Seven D, Dalan AB, Bayrak OF. BMC Cancer 2025;25:1493.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seven D, Dalan AB, Bayrak OF. Targeting GSTM3 for therapeutic potential in advanced prostate cancer. BMC Cancer 2025;25:1493.
PMID: 41034761